These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30551992)

  • 1. Oral cyclosporine for severe vernal keratoconjunctivitis in children.
    Borrego-Sanz L; López Abad C; Méndez Fernández R; Pato Cour E; Díaz Valle D; Benítez Del Castillo JM; Rodríguez Rodríguez L
    J Fr Ophtalmol; 2019 Jan; 42(1):e12-e13. PubMed ID: 30551992
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis.
    Gokhale NS; Samant R; Sharma V
    Indian J Ophthalmol; 2012; 60(3):220-3. PubMed ID: 22569387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis.
    Çoban-Karataş M; Özkale Y; Altan-Yaycıoğlu R; Sızmaz S; Pelit A; Metindoğan S; Cantürk-Uğurbaş S; Aydın-Akova Y
    Turk J Pediatr; 2014; 56(4):410-7. PubMed ID: 25818961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated large limbal nodule as the presenting feature of vernal keratoconjunctivitis.
    Sugandhi P; Arora R
    J Pediatr Ophthalmol Strabismus; 2007; 44(1):49-50. PubMed ID: 17274337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Images in clinical medicine. Giant papillae in vernal keratoconjunctivitis.
    Ram J; Agarwal A
    N Engl J Med; 2014 Apr; 370(17):1636. PubMed ID: 24758619
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis.
    Subedi K; Sharma B; Shrestha S
    Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.
    Caputo R; Pucci N; Mori F; De Libero C; Di Grande L; Bacci GM
    Int J Immunopathol Pharmacol; 2012; 25(3):775-80. PubMed ID: 23058030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm.
    Gokhale NS
    Indian J Ophthalmol; 2016 Feb; 64(2):145-8. PubMed ID: 27050351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
    Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
    Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy for vernal shield ulcer.
    Kumar S
    Clin Exp Optom; 2008 Jan; 91(1):111-4. PubMed ID: 18045257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.
    Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M
    Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab.
    de Klerk TA; Sharma V; Arkwright PD; Biswas S
    J AAPOS; 2013 Jun; 17(3):305-6. PubMed ID: 23607979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops].
    Ebihara N
    Arerugi; 2010 Nov; 59(11):1525-31. PubMed ID: 21119297
    [No Abstract]   [Full Text] [Related]  

  • 18. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.
    Secchi AG; Tognon MS; Leonardi A
    Am J Ophthalmol; 1990 Dec; 110(6):641-5. PubMed ID: 2248328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.